TrialJournal of cancer research and clinical oncology2012

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

Claus-Henning Köhne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.